Literature DB >> 6155965

Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.

G Sedvall, B Fyrö, B Gullberg, H Nybäck, F A Wiesel, B Wode-Helgodt.   

Abstract

In 60 physically and mentally healthy human subjects, lumbar cerebrospinal fluid was analysed by mass fragmentography for 5-HIAA, HVA and MOPEG. Individuals with a family history of psychiatric morbidity had significantly greater variation in monoamine metabolite concentrations than subjects without such a family history. In subjects with a family history of schizophrenic psychosis 5-HIAA and HVA concentrations were significantly higher than in subjects with depressive disorders within the family. For subjects with deviant 5-HIAA levels the probability of having a psychiatric family history was 2.7 times higher than in subjects with normal values. For HVA and MOPEG similar relationships, but of a lower significance level, were found. The results suggest that the cerebral monoaminergic transmitter amines play critical roles in the pathophysiology of psychotic and depressive disorders with a family disposition. They also indicate a value of monoamine metabolite determination in CSF for the prediction of family vulnerability for psychiatric morbidity in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155965     DOI: 10.1192/bjp.136.4.366

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  16 in total

1.  Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients.

Authors:  B G Almay; F Johansson; L von Knorring; G Sedvall; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1980-02       Impact factor: 4.530

2.  Comment to "Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal".

Authors:  T Geijer; E Jönsson; J Neiman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

3.  5-hydroxytryptophol in the cerebrospinal fluid and urine of alcoholics and healthy subjects.

Authors:  O Beck; S Borg; L Eriksson; A Lundman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

4.  Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

Authors:  E G Jönsson; D Goldman; G Spurlock; J P Gustavsson; D A Nielsen; M Linnoila; M J Owen; G C Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 5.  The use of diet and dietary components in the study of factors controlling affect in humans: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

6.  Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents.

Authors:  S Borg; H Kvande; P Valverius
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children.

Authors:  J M Launay; C Bursztejn; P Ferrari; C Dreux; A Braconnier; E Zarifian; S Lancrenon; J Fermanian
Journal:  J Autism Dev Disord       Date:  1987-09

8.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

9.  Childhood psychosis and monoamine metabolites in spinal fluid.

Authors:  C Gillberg; L Svennerholm; C Hamilton-Hellberg
Journal:  J Autism Dev Disord       Date:  1983-12

Review 10.  Clinical investigation of monoamine neurotransmitter interactions.

Authors:  J K Hsiao; W Z Potter; H Agren; R R Owen; D Pickar
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.